Evidence map›Paper›PMID 41219829›Full record

Trial reportBMC gastroenterology2025

Prehabilitation for patients undergoing endoscopic submucosal dissection: a randomized controlled trial.

Biyun Jiang, Shengdi Lu, Yiling Yan, Ruixin Wang, Manrong Xu, Lihua Huang, Yun Shen

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Biyun Jiang *Department of Nursing, Shanghai Sixth People's Hospital, Shanghai, China.
Shengdi Lu *Pennington Biomedical Research Center, 6400 Perkins Rd, Baton Rouge, LA, 70808, US.
Yiling YanDepartment of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Ruixin WangSchool of Public Health, Fudan University, Shanghai, China.
Manrong XuDepartment of Endocrinology and Metabolism, Shanghai Sixth People's Hospital, Shanghai, China.
Lihua HuangDepartment of Rehabilitation Medicine, Shanghai Sixth People's Hospital, 600 Yishan Road, Shanghai, 200233, China. huanglihua906@163.com.
Yun ShenPennington Biomedical Research Center, 6400 Perkins Rd, Baton Rouge, LA, 70808, US. Yun.Shen@pbrc.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndoscopic submucosal dissection (ESD) is a minimally invasive therapy for early gastrointestinal neoplasms, but patients may experience reduced functional capacity and delayed recovery post-procedure. Prehabilitation, has shown benefits in major surgery by improving physical fitness and recovery. We hypothesized that a structured prehabilitation regimen before ESD would enhance postoperative functional recovery and patient outcomes compared to standard care.

methodsSingle-center, assessor-blinded randomized controlled trial of 100 adults undergoing elective ESD, randomized to 4-week prehabilitation (supervised aerobic/resistance training 3×/week, individualized nutrition with protein supplementation, and psychological support) or usual care (standard instructions without structured exercise or nutrition). The primary outcome was change in six-minute walk distance (6MWD) from baseline to 1 month. Secondary outcomes included handgrip strength, quality of life (SF-36), psychological health (HADS), postoperative complications, length of stay, and 90-day readmissions.

resultsBaseline characteristics were similar between groups. At 1-month post-ESD, six-minute walk distance had decreased in both groups with no significant between-group difference (mean change from baseline - 40.9 m in prehabilitation vs. - 53.3 m in controls, p = 0.439). By 3 months, the prehabilitation group surpassed their baseline walking distance (18.9 m), whereas controls remained below baseline (- 14.1 m), indicating superior functional recovery with prehabilitation (p = 0.022). Prehabilitation also led to greater improvements in early postoperative strength and patient-reported outcomes. At 1 month, handgrip strength increased more in the prehabilitation group (mean 5.6 kg vs. 4.1 kg, p = 0.001). Anxiety symptoms improved significantly with prehabilitation (HADS anxiety score change - 1.17 vs. - 0.22, p = 0.003), with a parallel significant reduction in depression scores (p = 0.002). Prehabilitation patients reported higher gains in mental quality-of-life by 3 months (SF-36 mental component + 15.4 vs. + 11.4 points, p < 0.001). There were no significant differences in perioperative safety outcomes, average hospital stay, and 90-day readmission rates.

conclusionsA 4-week multimodal prehabilitation program for ESD patients significantly improved postoperative functional capacity and psychological well-being without increasing complication rates or hospital stay. Prehabilitation is a safe and effective strategy to enhance recovery and patient-centered outcomes in ESD. CLINICAL

trial registrationThis trial was retrospectively registered in the Chinese Clinical Trial Registry (ChiCTR) (registration number: ChiCTR2500103062) on May 23, 2025. LEVEL OF EVIDENCE: Level I (Randomized Controlled Trial).

Indexed as

Endoscopic Mucosal ResectionGastrointestinal NeoplasmsPreoperative CarePreoperative ExerciseAgedFemaleHand StrengthHumansLength of StayMaleMiddle AgedPatient ReadmissionPostoperative ComplicationsQuality of LifeRecovery of FunctionResistance TrainingEndoscopic submucosal dissectionFunctional recoveryPrehabilitationQuality of lifeRandomized controlled trial

Identifiers

PMID41219829
PMCPMC12607201

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.